Niraparib nearly doubles progression-free survival in prostate cancer with specific genetic mutations
Men with prostate cancer whose tumors have specific genetic mutations saw a nearly 50 percent reduction in the risk of cancer progression when they received naraparib.
Slightly higher dose radiation therapy over fewer weeks just as effective as standard regimen for early stage prostate cancer
Prostate cancer patients who received shorter, higher-dose course radiation treatment (MHFRT) had the same cancer control rates as those...
Advanced imaging detects prostate cancer spread better than x-rays or CT-scans
Man undergoing PSMA-PET scan – image credit UCLA Health CANCER DIGEST – Jan. 5, 2025 – Nearly half of high-risk prostate cancer patients...
MRI-first allows men to avoid biopsy for prostate cancer detection
Dr. Charlie Hamm, first author of the study and physician at Charité's Department of Radiology, in front of a magnetic resonance imaging...
Diet rich in omega 3 foods may slow progression in early stage prostate cancer
Men with prostate cancer who have chosen "watchful waiting" or surveillance might be able to extend the time before more aggressive treatmen
Combination treatment shows promise for rare, fatal cancersÂ
CANCER DIGEST – Nov. 17, 2024 – Researchers at UCLA have found that combining an immunotherapy drug with chemotherapy significantly...
